Table 2:
Calculated hemolysis index (HI), mg/dL hemoglobin, required to increase ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) concentration by 10% and to reach 400 pg/mL, based on quadratic models.
| Patient | Baseline UCH-L1 concentration (pg/mL) | Baseline HI | UCH-L1 concentration increased by 10% | HI required for 10% UCH-L1 increase | HI required to reach 400 pg/mL of UCH-L1 | Quadratic equation |
|---|---|---|---|---|---|---|
| 1 | 44 | 3 | 48 | 17 | 2106 | 43,5 + 0,259x - 4,26E-05x2 =y |
| 2* | 58 | 0 | 64 | 13 | 856 | 58.7 + 0.405x - 7.17E–06x2 =y |
| 3* | 65 | 11 | 71 | 40 | 2275 | 64,6 + 0,161x - 5,97E-06x2 =y |
| 4 | 68 | 1 | 74 | 13 | 754 | 66.9 + 0.549x - 1.42E–04x2 =y |
| 5 | 81 | 2 | 89 | 42 | 1795 | 78,3 + 0,257x - 7,16E-05x2 =y |
| 6* | 96 | 1 | 106 | 39 | 1929 | 95,5 + 0,272x - 7,05E-05x2 =y |
| 7 | 106 | 1 | 116 | 26 | 723 | 105 + 0.441x - 4.59E–05x2 =y |
| 8 | 122 | 4 | 134 | 24 | 559 | 122 + 0,502x - 7,68E-06x2 =y |
| 9* | 134 | 1 | 148 | 194 | 2103 | 134 + 0.0668x + 2.84E–05x2 =y |
| 10* | 136 | 1 | 149 | 73 | 1484 | 139 + 0.134x + 2.82E–05x2 =y |
| 11 | 140 | 3 | 154 | 25 | 369 | 134 + 0.807x - 2.33E-04x2 =y |
| 12 | 142 | 10 | 156 | 42 | 775 | 139 + 0,41x - 9,47E-05x2 =y |
| 13 | 158 | 5 | 174 | 84 | 1310 | 156 + 0,216x - 2,27E-05x2 =y |
| 14 | 169 | 59 | 186 | 102 | 1009 | 153 + 0,341x - 1,69E-04x2=y |
| 15 | 178 | 2 | 196 | 33 | 573 | 177 + 0.583x - 3.38E–04x2=y |
| 16 | 232 | 110 | 255 | 171 | 468 | 171 + 0,492x - 5,63E-06x2=y |
| 17 | 247 | 38 | 272 | 195 | 968 | 241 + 0.158x + 6.44E–06 x2=y |
| 18 | 262 | 73 | 288 | 138 | 269 | 154 + 1,03x + -4,29E-04x2=y |
| 19 | 413 | 54 | 455 | 95 | N/A | 350 + 1,13x + -2,02E-04x2=y |
| 20 | 1183 | 164 | 1301 | 808 | N/A | 1206 + -0,232x + 4,33E-04x2=y |
The equations were derived from individually fitted quadratic models describing the relationship between the HI and the measured UCH-L1 concentration in samples with progressively increasing hemolysis. The patients’ results are shown in order of increasing baseline UCH-L1 concentration.
*Serum samples (*); remaining samples are lithium heparin plasma.
N/A: not appicable